First Citizens Bank & Trust Co. Makes New Investment in agilon health, inc. (NYSE:AGL)

First Citizens Bank & Trust Co. purchased a new stake in shares of agilon health, inc. (NYSE:AGL) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 24,117 shares of the company’s stock, valued at approximately $46,000.

A number of other hedge funds have also modified their holdings of AGL. Inspire Investing LLC lifted its stake in shares of agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after buying an additional 112,241 shares in the last quarter. Oak Thistle LLC bought a new stake in agilon health during the fourth quarter valued at about $25,000. Pines Wealth Management LLC purchased a new position in shares of agilon health in the fourth quarter valued at about $51,000. JPMorgan Chase & Co. boosted its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares during the period. Finally, Virtu Financial LLC bought a new position in shares of agilon health in the third quarter worth about $120,000.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Macquarie began coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Royal Bank of Canada restated an “outperform” rating and set a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Finally, Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $4.03.

agilon health Stock Up 3.7 %

Shares of agilon health stock opened at $3.52 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a market capitalization of $1.45 billion, a P/E ratio of -3.74 and a beta of 0.53. The company has a 50 day moving average of $2.34 and a 200 day moving average of $3.49.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the business posted ($0.06) EPS. As a group, research analysts forecast that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Insider Buying and Selling at agilon health

In related news, Director Diana Mckenzie purchased 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now directly owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 90,000 shares of company stock worth $198,100. 3.20% of the stock is owned by insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.